Lee Chee-Yee, Lin Pei-Hsuan, Tsai Cheng-Yu, Chiang Yu-Ting, Chiou Hong-Ping, Chiang Ko-Yin, Chen Pei-Lung, Hsu Jacob Shu-Jui, Liu Tien-Chen, Wu Hung-Pin, Wu Chen-Chi, Hsu Chuan-Jen
Department of Otolaryngology-Head and Neck Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 42743, Taiwan.
School of Medicine, College of Medicine, Tzu Chi University, Hualien 97074, Taiwan.
Biomedicines. 2022 Jul 31;10(8):1846. doi: 10.3390/biomedicines10081846.
Cochlear implantation is the treatment of choice for children with profound sensorineural hearing impairment (SNHI), yet the outcomes of cochlear implants (CI) vary significantly across individuals. To investigate the CI outcomes in pediatric patients with SNHI due to various etiologies, we prospectively recruited children who underwent CI surgery at two tertiary referral CI centers from 2010 to 2021. All patients underwent comprehensive history taking, next generation sequencing (NGS)-based genetic examinations, and imaging studies. The CI outcomes were evaluated using Categories of Auditory Performance (CAP) and Speech Intelligibility Rating (SIR) scores. Of the 160 pediatric cochlear implantees (76 females and 84 males) included in this study, comprehensive etiological work-up helped achieve clinical diagnoses in 83.1% (133/160) of the patients, with genetic factors being the leading cause (61.3%). Imaging studies identified certain findings in 31 additional patients (19.3%). Four patients (2.5%) were identified with congenital cytomegalovirus infection (cCMV), and 27 patients (16.9%) remained with unknown etiologies. Pathogenic variants in the four predominant non-syndromic SNHI genes (i.e., SLC26A4, GJB2, MYO15A, and OTOF) were associated with favorable CI outcomes (Chi-square test, p = 0.023), whereas cochlear nerve deficiency (CND) on imaging studies was associated with unfavorable CI outcomes (Chi-square test, p < 0.001). Our results demonstrated a clear correlation between the etiologies and CI outcomes, underscoring the importance of thorough etiological work-up preoperatively in pediatric CI candidates.
人工耳蜗植入是重度感音神经性听力损失(SNHI)儿童的首选治疗方法,但人工耳蜗(CI)的治疗效果在个体间差异很大。为了研究不同病因导致的小儿SNHI患者的CI治疗效果,我们前瞻性地招募了2010年至2021年在两个三级转诊CI中心接受CI手术的儿童。所有患者均接受了全面的病史采集、基于二代测序(NGS)的基因检测和影像学检查。使用听觉表现分类(CAP)和言语可懂度评分(SIR)对CI治疗效果进行评估。本研究纳入的160名小儿人工耳蜗植入者(76名女性和84名男性)中,全面的病因检查帮助83.1%(133/160)的患者获得了临床诊断,其中遗传因素是主要原因(61.3%)。影像学检查在另外31名患者(19.3%)中发现了某些异常。4名患者(2.5%)被诊断为先天性巨细胞病毒感染(cCMV),27名患者(16.9%)病因不明。四个主要的非综合征性SNHI基因(即SLC26A4、GJB2、MYO15A和OTOF)中的致病变异与良好的CI治疗效果相关(卡方检验,p = 0.023),而影像学检查发现的耳蜗神经缺损(CND)与不良的CI治疗效果相关(卡方检验,p < 0.001)。我们的结果表明病因与CI治疗效果之间存在明显的相关性,强调了术前对小儿CI候选者进行全面病因检查的重要性。